Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
07/1998
07/01/1998EP0850316A1 Cryptophycins from aberrant biosynthesis
07/01/1998EP0850221A1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
07/01/1998EP0850057A1 Pharmaceutical compounds
07/01/1998EP0695308B1 Novel heterocyclic acyldipeptides, processes for the preparation thereof and pharmaceutical compositions containing the same
07/01/1998EP0654041B1 Peptidyl 4-amino-2,2-difluoro-3-oxo-1,6-hexanedioic acid derivatives as antiinflammatory agents
07/01/1998CN1186499A Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
07/01/1998CN1038939C Preparation of peptide compounds
06/1998
06/30/1998US5773652 Method for isolation and purification of S-(1,2-dicarboxyethyl) glutathione
06/30/1998US5773640 Platinum catalysis reaction of 3,3-dimethylbutyraldehyde and aspartame
06/30/1998US5773602 DNA fragments obtained from a novel human immunodeficiency virus designated LAVMAL
06/30/1998US5773598 Systematic evolution of ligands by exponential enrichment: chimeric selex
06/30/1998US5773579 Comprising a membrane ion and a phosphorylation site; exhibits carbonic anhydrase activity
06/30/1998US5773575 Reacting a carboxylic acid and amine with coupling agent
06/30/1998US5773571 Peptide nucleic acids
06/30/1998US5773455 Inhibitors of prenyl transferases
06/30/1998US5773438 Synthetic matrix metalloprotease inhibitors and use thereof
06/30/1998US5773414 Endothelin antagonists
06/30/1998US5773412 Use of peptides for altering αV β3 -mediated binding
06/30/1998US5773411 Cardiovascular disorders and brain disorders and coagulants
06/30/1998US5773236 Assay for glutathiane transferase using polyhaloaryl-substituted reporter molecules
06/25/1998WO1998027109A1 Cycloalkyl inhibitors of protein farnesyltransferase
06/25/1998WO1998026793A1 Synthetic antibiotics
06/25/1998WO1998026773A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing
06/25/1998WO1998026660A1 Cd4-mimetic ligands
06/25/1998CA2264692A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing
06/25/1998CA2264207A1 Cycloalkyl inhibitors of protein farnesyltransferase
06/24/1998EP0849256A1 Amide compounds and use of the same
06/24/1998EP0679161B1 Thiazolidine derivatives, preparation thereof and drugs containing same
06/24/1998EP0666842B1 Hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
06/24/1998CN1185786A Sugar-modified cytostatics
06/24/1998CN1185785A Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic use
06/23/1998US5770692 Method of introducing ureido groups into peptides while preserving stereochemistry
06/23/1998US5770620 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors
06/23/1998US5770600 Methionine sulfone and S-substituted cysteine sulfone derivatives as enzyme inhibitors
06/23/1998US5770576 Administering glutamic acid-tryptophan dipeptide to stimulate binding function of t-lymphocytes
06/23/1998US5770574 Long-chain alkylamides of amino acids and peptides with anti-proliferative and anti-inflammatory properties
06/23/1998US5770573 CS-1 peptidomimetics, compositions and methods of using the same
06/23/1998US5770565 Peptides for reducing or inhibiting bone resorption
06/23/1998US5770455 Identifier tag which is a microchip that is pre-encoded or encodable with information that is related back to a detector when the tag is pulsed with electromagnetic radiation
06/23/1998US5770358 Tagged synthetic oligomer libraries
06/23/1998US5770178 Metal chelate forming peptides and use thereof
06/23/1998CA2021180C Process for the preparation of .alpha.-l-aspartyl-l-phenylalanine methyl ester hydrochloride by use of isolated n-formyl-aspartic anhydride
06/20/1998CA2225273A1 Vitronectin receptor antagonists, their preparation and their use
06/18/1998WO1998025965A2 Peptides and compounds that bind to the thrombopoietin receptor
06/18/1998WO1998025950A1 Polyprolyl inhibitors of cyclophilin
06/18/1998WO1998025949A1 Substituted 5-amino-1,3,4-thiadiazole-2-thiones
06/18/1998WO1998025883A1 Ketobenzamides as calpain inhibitors
06/18/1998WO1998025589A1 Active agent transport systems
06/18/1998WO1998016523A3 Selective factor xa inhibitors
06/18/1998WO1998006742A3 Peptides for treatment of inflammation and shock
06/18/1998CA2263828A1 Polyprolyl inhibitors of cyclophilin
06/17/1998EP0847400A1 Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin
06/17/1998EP0689549B1 New urea derivates, their preparation and their use
06/17/1998EP0636142B1 Lactam peptides having hle inhibiting activity
06/17/1998EP0500745B1 Metal-peptide compositions and cosmetic methods for stimulating hair growth
06/17/1998CN1185160A Peptide and method for obtg. same
06/17/1998CN1038747C Prepn. method and use of sweetening agent, and composite compound therefor
06/16/1998US5767290 Preparation of protected amines or alkylated amino acids
06/16/1998US5767274 Treating tumors or restenosis
06/16/1998US5767254 Method for making amino acid glycosides and glycopeptides
06/16/1998US5767237 Antitumor agents
06/16/1998US5767118 4-Heterocyclic peperidines promote release of growth hormone
06/16/1998US5767088 Useful for treating pain, inflammation, smooth muscle contraction and inducing vasodilation
06/16/1998US5767087 Administering purified glutamic acid-tryptophan dipeptide toincrease number of lymphocytes or karyocytes in non-human animal
06/16/1998US5767086 Administering cytoprotective cell differentiation stimulant to bone marrow
06/16/1998US5767085 Peptide derivatives
06/16/1998US5767083 Inhibition of melanocyte stimulatting hormone
06/16/1998US5766963 Combination hydroxypropylamine library
06/16/1998US5766932 Resolving a racemic mixture; chemical intermediate
06/16/1998US5766927 Stabilizing the protein by contacting the cell with a dipeptide having an n-terminal amino acid residue selected form the group consists of arginine, lysins and histidine
06/16/1998US5766855 Peptide nucleic acids having enhanced binding affinity and sequence specificity
06/16/1998US5766556 Apparatus and method for multiple simultaneous synthesis
06/11/1998WO1998024814A2 N-terminally modified polypeptide enzyme inhibitors, and related therapeutic methods and pharmaceutical compositions
06/11/1998WO1998024809A1 Peptides agonists of bradykinine b2 receptor
06/11/1998WO1998024806A2 Substituted oxadiazole, thiadiazole and triazole serine protease inhibitors
06/11/1998WO1998024805A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
06/11/1998WO1998024804A2 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
06/11/1998WO1998024774A1 Macrocyclic metal complex carboxylic acids, use and method for the production thereof
06/11/1998WO1998024770A1 New histidine derivatives, preparation process, and their use as free antiradical agents
06/11/1998WO1998024461A1 Peptide synthesis with sulfonyl protecting groups
06/11/1998WO1998002461A3 Liquid phase peptide syntheses of kl-4 pulmonary surfactant
06/11/1998CA2274250A1 Inhibitors of interleukin-1.beta. converting enzyme
06/11/1998CA2274249A1 Inhibitors of interleukin-1.beta. converting enzyme
06/11/1998CA2273857A1 Peptide synthesis with sulfonyl protecting groups
06/11/1998CA2273190A1 Peptides agonists of bradykinine b2 receptor
06/11/1998CA2272548A1 Serine protease inhibitors
06/10/1998EP0846682A1 Penicillaminamide derivatives
06/10/1998EP0846127A1 Acylated oligopeptide derivatives having cell signal inhibiting activity
06/10/1998EP0846126A1 Tricyclic antidepressant derivatives and conjugated useful in immunoassays
06/10/1998EP0846125A2 INHIBITORS OF FACTOR Xa
06/10/1998EP0846110A1 Thf-containing sulfonamide inhibitors of aspartyl protease
06/10/1998EP0845987A1 C-proteinase inhibitors for the treatment of disorders related to the overproduction of collagen
06/10/1998EP0629210B1 Peptide linkage unit comprising methylene phosphinic acid
06/10/1998DE19652387A1 Macrocyclische Metallkomplexcarbonsäuren, ihre Verwendung sowie Verfahren zu ihrer Herstellung Macrocyclic metal complex carboxylic acids, their use and processes for their preparation
06/10/1998CN1184472A Reversible protease inhibitors
06/09/1998US5763631 Irreversible HIV protease inhibitors, intermediates, compositions and processes for the preparation thereof
06/09/1998US5763604 Anticoagulants
06/09/1998US5763576 Tetrapeptide α-ketoamides
06/09/1998US5763570 Glutathione analogs and paralog panels comprising glutathione mimics
06/09/1998US5763408 Tumor metastasis inhibitors
1 ... 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 ... 307